LC-MS/MS metabolomics profiling of Glechoma hederacea L. methanolic extract; in vitro antimicrobial and in vivo with in silico wound healing studies on Staphylococcus aureus infected rat skin wound
LC-MS/MS analysis of Glechoma hederacea L. methanolic extract (GHME), revealed the identification of 25 metabolites. Ursolic acid (1), 2α-hydroxyursolic acid or corosolic acid (2), 2β-hydroxyursolic acid or epi-corosolic (3), luteolin 7-O-β-D-glucopyranoside (4) and rosmarinic acid (5) were isolated and identified using spectroscopy. Antibacterial activity of GHME against multi drug resistance Staphylococcus aureus clinical isolates was measured. Minimum inhibitory concentrations (MICs) were ranged from 62.5 to 500 µg/ml. In vivo wound healing potential of 2%, and 5% GHME prepared hydrogels were criticized on Staphylococcus aureus infected wound rat model. 5% GHME prepared hydrogel treated group showed significant (p < 0.05) shrinkage of their colony forming unit/ml (CFU/ml) values in comparison with standard Fucidin. Meanwhile, wound closure associated with full re-epithelization and hair follicles proliferation was noticed after ten days of treatment. Finally, among the GHME isolated compounds, luteolin 7-O-β-D-glucopyranoside (4) exhibited the highest molecular docking score (-9.6 kcal/mol) against matrix metalloproteinase-8 target (MMP-8).
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
---|---|
Enthalten in: |
Natural product research - 37(2023), 10 vom: 12. Mai, Seite 1730-1734 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
El-Aasr, Mona [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 20.04.2023 Date Revised 20.04.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/14786419.2022.2108421 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM344623092 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM344623092 | ||
003 | DE-627 | ||
005 | 20231226023212.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/14786419.2022.2108421 |2 doi | |
028 | 5 | 2 | |a pubmed24n1148.xml |
035 | |a (DE-627)NLM344623092 | ||
035 | |a (NLM)35942893 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a El-Aasr, Mona |e verfasserin |4 aut | |
245 | 1 | 0 | |a LC-MS/MS metabolomics profiling of Glechoma hederacea L. methanolic extract; in vitro antimicrobial and in vivo with in silico wound healing studies on Staphylococcus aureus infected rat skin wound |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.04.2023 | ||
500 | |a Date Revised 20.04.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a LC-MS/MS analysis of Glechoma hederacea L. methanolic extract (GHME), revealed the identification of 25 metabolites. Ursolic acid (1), 2α-hydroxyursolic acid or corosolic acid (2), 2β-hydroxyursolic acid or epi-corosolic (3), luteolin 7-O-β-D-glucopyranoside (4) and rosmarinic acid (5) were isolated and identified using spectroscopy. Antibacterial activity of GHME against multi drug resistance Staphylococcus aureus clinical isolates was measured. Minimum inhibitory concentrations (MICs) were ranged from 62.5 to 500 µg/ml. In vivo wound healing potential of 2%, and 5% GHME prepared hydrogels were criticized on Staphylococcus aureus infected wound rat model. 5% GHME prepared hydrogel treated group showed significant (p < 0.05) shrinkage of their colony forming unit/ml (CFU/ml) values in comparison with standard Fucidin. Meanwhile, wound closure associated with full re-epithelization and hair follicles proliferation was noticed after ten days of treatment. Finally, among the GHME isolated compounds, luteolin 7-O-β-D-glucopyranoside (4) exhibited the highest molecular docking score (-9.6 kcal/mol) against matrix metalloproteinase-8 target (MMP-8) | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Glechoma hederacea L. | |
650 | 4 | |a LC-MS/MS | |
650 | 4 | |a Staphylococcus aureus | |
650 | 4 | |a in vivo wound healing studies | |
650 | 4 | |a luteolin 7-O-β-D-glucopyranoside | |
650 | 4 | |a matrix metalloproteinase-8 target | |
650 | 4 | |a multidrug resistance | |
650 | 7 | |a Luteolin |2 NLM | |
650 | 7 | |a KUX1ZNC9J2 |2 NLM | |
650 | 7 | |a Anti-Infective Agents |2 NLM | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
650 | 7 | |a Plant Extracts |2 NLM | |
700 | 1 | |a Nohara, Toshihiro |e verfasserin |4 aut | |
700 | 1 | |a Ikeda, Tsuyushi |e verfasserin |4 aut | |
700 | 1 | |a Abu-Risha, Sally E |e verfasserin |4 aut | |
700 | 1 | |a Elekhnawy, Engy |e verfasserin |4 aut | |
700 | 1 | |a Tawfik, Haytham O |e verfasserin |4 aut | |
700 | 1 | |a Shoeib, Nagwa |e verfasserin |4 aut | |
700 | 1 | |a Attia, Ghada |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Natural product research |d 2003 |g 37(2023), 10 vom: 12. Mai, Seite 1730-1734 |w (DE-627)NLM124466303 |x 1478-6427 |7 nnns |
773 | 1 | 8 | |g volume:37 |g year:2023 |g number:10 |g day:12 |g month:05 |g pages:1730-1734 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/14786419.2022.2108421 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 37 |j 2023 |e 10 |b 12 |c 05 |h 1730-1734 |